Ardelyx (ARDX) Other Accumulated Expenses (2013 - 2020)
Ardelyx (ARDX) posted Other Accumulated Expenses of $285000.0 for Q4 2020, down 61.95% on a QoQ basis from $749000.0 in Q4 2019, and down 61.95% year-over-year from $749000.0 in Q1 2020.
Ardelyx (ARDX) Other Accumulated Expenses (2013 - 2020) Analysis & Trends
Ardelyx's Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $285000.0 for Q4 2020.
- Quarterly Other Accumulated Expenses fell 61.95% year-over-year to $285000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $285000.0 (down 61.95% YoY) and the FY2020 annual result came in at $285000.0, down 61.95% from the prior year.
- Other Accumulated Expenses was $285000.0 for Q4 2020 at Ardelyx, down from $749000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $984000.0 in Q1 2018 and bottomed at $170000.0 in Q3 2019.
- A 5-year average of $623000.0 and a median of $700000.0 in 2017 frame the typical range for Other Accumulated Expenses.
- Peak annual rise in Other Accumulated Expenses reached 98.15% in 2019, while the deepest fall reached 82.58% in 2019.
- Ardelyx's Other Accumulated Expenses stood at $684000.0 in 2016, then climbed by 9.94% to $752000.0 in 2017, then slumped by 49.73% to $378000.0 in 2018, then jumped by 98.15% to $749000.0 in 2019, then slumped by 61.95% to $285000.0 in 2020.
- Business Quant data shows ARDX's Other Accumulated Expenses at $285000.0 in Q4 2020, $749000.0 in Q4 2019, and $170000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 285,000.00 |
| Dec 31, 2019 | 749,000.00 |
| Sep 30, 2019 | 170,000.00 |
| Jun 30, 2019 | 222,000.00 |
| Mar 31, 2019 | 211,000.00 |
| Dec 31, 2018 | 378,000.00 |
| Sep 30, 2018 | 976,000.00 |
| Jun 30, 2018 | 844,000.00 |
| Mar 31, 2018 | 984,000.00 |
| Dec 31, 2017 | 752,000.00 |
| Sep 30, 2017 | 700,000.00 |
| Jun 30, 2017 | 855,000.00 |
| Mar 31, 2017 | 647,000.00 |
| Dec 31, 2016 | 684,000.00 |
| Sep 30, 2016 | 824,000.00 |
| Jun 30, 2016 | 771,000.00 |
| Mar 31, 2016 | 539,000.00 |
| Dec 31, 2015 | 380,000.00 |
| Sep 30, 2015 | 845,000.00 |
| Dec 31, 2014 | 780,000.00 |